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Comparing service use and costs among adolescents with autism spectrum disorders, special 
needs and typical development 
 
Abstract 
Autism spectrum disorder (ASD) is a complex condition that can require specialised care. Knowledge 
of the costs of ASD, especially in comparison with other conditions, may be useful to galvanise policy 
makers and leverage investment in education and intervention to mitigate aspects of ASD that 
negatively impact individuals with the disorder and their families. This paper describes the services 
and associated costs for four groups of individuals: adolescents with autistic disorder, adolescents 
with other ASDs, adolescents with other special educational needs (SEN) and typically developing 
adolescents using data from a large-well characterised cohort assessed as part of the UK Special 
Needs and Autism Project at 12 years old. Average total costs per participant over six months were 
highest in the autistic disorder group (£11029), followed by the SEN group (£9268), the broader ASD 
group (£8968) and the typically developing group (£2954). Specialised day or residential schooling 
accounted for the vast majority of costs. In regression analysis, lower age and lower adaptive 
functioning were associated with higher costs in the groups with an autism spectrum disorder. Sex, 
ethnicity, number of ICD-10 symptoms, ASD symptom scores and levels of mental health difficulties 
were not associated with cost.  
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Introduction 
Autism spectrum disorder (ASD) is a complex condition which presents both difficulties and 
strengths the individual and both challenges and opportunities for society. A number of recent 
studies have estimated the economic costs associated with ASD. Whilst the value of an individual 
cannot and should not be considered in terms of monetary costs, estimating the economic costs 
associated with ASD may be useful to galvanise policy makers and leverage investment in education 
and intervention to mitigate aspects of ASD that negatively impact individuals’ and families’ 
adaptation and choices.  
 
Previous research has found that the costs of autism in childhood are borne primarily by both 
publicly funded services (health, education, social services) and families (Barrett et al. 2011; Jarbrink 
et al. 2003). One study estimated that the total costs of supporting children with ASD in the UK was 
approximated at £2.7 billion per year, of which 95% was accounted for by services funded by the 
state with the remaining 5% falling to families (Knapp et al. 2009). The cost of ASD to the health 
care, social care and education systems is high compared with other childhood illnesses such as 
diabetes and asthma (Flanders et al. 2006) and intellectual disabilities (Mandell et al. 2006). Health 
care costs are substantial; the estimated mean cost of medical expenditure for people with autism 
spectrum disorders in the US ranges between $2,100 and £11,200 per individual per year with costs 
highest for young children (Amendah et al. 2011). Research in the USA has found that health care 
utilisation costs are substantially higher for children with ASD than for those without ASD (Croen et 
al. 2006).  Education costs also are considerable; children with ASD are significantly more likely to 
use special education education services than those without ASD (Lavelle et al. 2013). The costs that 
fall to families are made up of out-of-pocket costs such as additional non- funded treatments, 
informal care and lost productivity. These costs are difficult to estimate; one study in the US found 
that childhood autism spectrum disorders are associated with substantial loss of household income 
(Montes et al. 2012) and informal care costs were found to account for 5% of total costs of young 
adults with high functioning autism (Cidav et al. 2012).  
 
People with ASD, their families and the professionals responsible for their care and education seek 
to maximise their well-being within the resources that are available to them. Ultimately this can be 
achieved through knowledge of the cost-effectiveness of programmes and interventions. Where this 
information is limited, a first step is to capture how resources are currently used and to investigate 
the associations between individual characteristics and costs. To this end, in this paper we describe 
the service use and service costs for four groups of individuals: adolescents with autistic disorder, 
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adolescents with a other ASDs; adolescents with other childhood special educational needs (SEN)1 
and typically developing adolescents. We first compare the service use and associated costs of these 
groups; comparing the cost of ASD and SEN to a typically developing control group allows 
meaningful conclusions to be made about the incremental costs of ASD and other SEN in 
adolescence and provides a baseline against which the economic impact of new interventions can be 
assessed.  
 
In the second part of the paper, and for the ASD groups only, we conduct a regression analysis in 
order to explore the associations between individual characteristics and costs. Knowledge of the 
characteristics of young people who require high cost services can support planning in health, social 
care and education systems. In addition it can also influence the direction of future economic 
evaluations, which should be focused on areas of high cost in order to ensure that the resources 
cannot be better spent elsewhere.  
 
Methods 
Participants and measures 
We analysed data from a large, well-characterised cohort of adolescents with ASDs and other special 
needs who had been assessed as part of the UK Special Needs and Autism Project (SNAP) at age 12 
years (range 9.8-14.4)(Baird et al. 2006). Expert consensus ICD-10 (World Health Organization 1993) 
clinical diagnosis (authors GB, ES, TC) of ASDs (including pervasive developmental disorder-other and 
atypical autism) was based on the Autism Diagnostic Interview – Revised (ADI-R; Lord et al. 1994) 
and the Autism Diagnostic Observation Schedule (ADOS-G; Lord et al. 2000). The total number of 
ICD-10 autism symptoms was recorded. In addition IQ (Wechsler Abbreviated Scale of Intelligence, 
WASIUK; (Wechsler 1999), adaptive behaviour using the Vineland adaptive behaviour scale (VABS;  
Sparrow et al. 1984) and mental health difficulties using the Strengths and Difficulties Questionnaire 
(SDQ;  Goodman 1997) were measured. The SEN group consisted of children who had not met 
criteria for an ASD but who had a range of primary ICD-10 diagnoses including intellectual disability 
(IQ<70) (n=19), language delay/language disorder (n=2), learning difficulties (n=2) and ADHD (n=2). A 
later phase of SNAP revisited children with ASD and SEN in adolescence for a thorough cognitive 
assessment (Charman et al. 2011) and included an additional sample of typically developing 
adolescents. The typically developing group was recruited from mainstream schools and had no 
psychiatric or developmental disorder, no statement of special educational needs, and were not 
                                                          
1 A Statement of Special Educational Needs is a legal document issued by the UK local educational authority 
when children require significant additional support in school due to any learning and/or behavioural problems 
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taking any psychotropic medication. Data about service use and cost were collected at this second 
time point.  
 
Service use and costs for whole sample 
Resource use data were collected at the follow-up interview using the Child and Adolescent Service 
Use Schedule (CA-SUS), designed in previous research with young people and adapted for the 
purpose of this study (Byford et al. 2007). The CA-SUS collects data on the young person’s use of a 
range of services for the six months preceding interview and includes information on contacts with 
primary and secondary health care services, social services, non-statutory services and education 
including type of education (specialist or mainstream), classroom support, education support and 
school based health and social services. For the autism, broader ASD and SEN groups, the data were 
collected via interview with a parent. For the typically developing group, the participants themselves 
were interviewed. 
 
Total costs were calculated by multiplying each resource use item by an appropriate unit cost. All 
unit costs, in UK pound sterling, were for the financial year 2007-2008, the period over which the 
data were collected, and were obtained from a number of sources (British Medical Association and 
Royal Pharmaceutical Society of Great Britain 2007; Curtis 2008; Department of Health 2008). The 
costs of mainstream and specialist schooling and education support costs included only the cost 
element of specialist education that is in addition to mainstream provision (www.ofsted.gov.uk).  
 
The pattern of service use is described. Total costs are presented as mean cost per participant and 
the average costs for each of the childhood autism, broader ASD and SEN groups are compared with 
the typically developing group using standard parametric t-tests, despite the skewed nature of the 
cost data. The validity of the t-tests was confirmed using bias-corrected, non-parametric 
bootstrapping (repeat re-sampling); a recommended approach in the analysis of skewed cost data 
because the arithmetic mean is maintained (Barber and Thompson 2000).  
 
Regression analysis for the autism and broader ASD sample 
Subjects from the autism and the broader ASD groups were combined in the regression analysis. The 
following participant characteristics from the SNAP interviews were included in this analysis: 
 age, sex, ethnicity and parent’s occupational class – these demographic factors have been 
found to be significant predictors of costs in a study of pre-school children with autism 
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(Barrett et al 2011), adolescents with mental health problems (Byford et al. 2008) and 
adolescents with complex mental health care needs (Clark et al. 2005); 
 diagnosis – the sample included young people with a diagnosis of core autism and also those 
with broader ASD and we hypothesised that costs would be higher in those with core 
autism; 
 IQ at age 12– we hypothesised that individuals with a lower IQ would have higher service 
costs;  
 severity of autism symptoms at age 12– measured using current ADI scores,  ADOS scores 
and the number of ICD-10 symptoms. These measures have been found to be significant 
predictors in a younger sample (Barrett et al 2011); 
 functioning at age 12– we hypothesised that individuals with higher levels of functioning as 
measured by the Vineland would incur lower costs; 
 mental health difficulties at age 12– we hypothesised that costs would be higher for those 
with more mental health difficulties measured using the SDQ.  
 
Statistical associations between each of these variables and total service costs were estimated using 
linear regression and adjusted associations then were calculated using multiple regression. A 
significance level of 5% was used. The results of the model were subject to two checks: first, they 
were compared with the results from a non-parametric bootstrap regression in order to assess the 
robustness of the confidence intervals and p-values given the non-normality of the cost distribution 
(Efron and Tibshirani 1993). Second, the results from the ordinary least squares regression were 
compared with the results obtained from a generalised linear model where a non-normal gamma 
distribution was assumed for costs (Blough et al. 1999). Statistical analyses were performed using 
Stata 11 (Stat Corp 2009).  
 
Results 
The CA-SUS was administered to 148 of the 157 participating families; missing data were due to 
limited parent availability or time constraints. 
 
Participant characteristics 
The young people in the study were on average aged 15 years (range 14 to 17), and predominantly 
male (92%) and white (83%) (Table 1). Further details of participant characteristics can be found in 
Baird et al. (2006) and Charman et al. (2011). 
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Service use 
Service use for the six months prior to interview is detailed in Table 2. Respite care was used by a 
fifth of the subjects with autistic disorder and by 7% and 4% of the broader ASD and SEN groups, 
respectively. Mainstream schools were attended by all the adolescents in the typically developing 
group and 73% of the adolescents in broader ASD group, but by less than half of the individuals in 
the childhood autism and SEN groups, who were more likely to be in special or residential education. 
Hospital inpatient stays were rare in all groups; outpatient appointments were common in the 
childhood autism, broader ASD and SEN groups and were also accessed by typically developing 
adolescents. Around half of the adolescents with SEN and typically development had one or more 
contacts with their GP. Medications (both prescribed and those purchased over the counter) were 
taken by between a quarter and a half of the young people in the sample.  
 
Total costs 
Table 3 details the total costs by service sector. Average total cost per participant over the six-month 
study period was highest in the childhood autism group (£11029), followed by the SEN group 
(£9268), the broader ASD group (£8968), and finally the typically developing group (£2954). The 
costs of education services constituted almost 90% of total costs in all groups. The average total cost 
per participant was significantly higher in the childhood autism (p<0.001), SEN (p<0.001) and 
broader ASD groups (p<0.001) than among typically developing youth. There were no significant 
differences in total costs among the autism, broader ASD and SEN groups.  
As is common in cost data, the distribution of costs was highly skewed, with a small number of 
participants driving up the mean cost of the group (Thompson and Barber 2000); this is 
demonstrated by the range in costs detailed in Table 3.  
 
Regression analysis 
The results of regression analysis are reported Table 4, which details the direction of cost change 
and the p-value for each regression. For continuous variables whilst analyses were carried out on the 
continuous data, for ease of presentation the difference in cost is shown in two groups split at the 
median. Significant predictors of cost were age, IQ, ADI – current communication score (poorer 
communication), ADOS – communication score (poorer communication), ADOS repetitive behaviour 
score (more repetitive behaviours) and Vineland composite standard score (poorer adaptive 
behaviour). There was no significant difference in service costs by sex, ethnicity or parent’s 
occupational class. Interestingly, the difference in cost between those with autism and broader ASD 
was not significant which suggests that there are more nuanced and subtle condition related 
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explanations for service use. In addition, ADI – current restrictive and repetitive behaviour score, 
ADOS – social score, ICD total symptoms and SDQ score were not significant predictors of cost.  
 
The results of the multivariate regression are detailed in Table 5. The table shows that for every 
yearly increase in age, costs fall by £4714 and for every unit increase in Vineland score costs fall by 
£188. The final model was able to account for around a quarter of the variation in cost (adjusted 
R2=0.25). Results from the bootstrap and GLM analyses were not substantially different from the OLS 
regression and are thus not reported here, but are available from the first author on request. 
 
Discussion 
Whilst a number of papers have estimated the service use and costs associated with autism in the 
UK (Barrett et al 2011; Knapp et al 2009), this is the first make the comparison with other special 
needs and typically developing controls. We have therefore been able to establish that childhood 
autism is a costly condition in adolescents; over six months, the total costs of services for 
adolescents with childhood autism were over £8000 more than those for typically developing 
adolescents. A comparable result was established in the US; Cidav and colleagues (2013) found that 
health service expenditures among children with autism were substantial and increased with age. 
However, we have also demonstrated that the cost of childhood autism is not uniquely high and that 
costs were not statistically different over six months than for adolescents with other special needs 
such as intellectual disability. For young people who do not meet the criteria for a clinical diagnosis 
of childhood autism yet have broader ASD, total costs were more than £2000 lower than for those 
with childhood autism.  
 
In common with the results found in an investigation of the costs of pre-school children with autism 
in the UK (Barrett et al 2011) and in a sample of children aged 3-17 in the US (Lavelle et al. 2014), in 
this adolescent population the key cost driver was education; costs were highest in those with 
childhood autism and SEN because of the specialist day and residential schooling that their needs 
require. In those with a broader ASD, average costs were lower because a greater proportion of the 
sample was able to attend a mainstream school (73% compared to 43% in the childhood autism 
group).  
 
In adjusted analysis, lower age and poorer adaptive behaviour were associated with higher costs. 
Whilst the sample consists of individuals in a narrow age band, we found that costs were 
significantly higher among slightly younger participants. Examination of the data suggests that this is 
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due to a reduction in the intensity of classroom support and specialist provision in post-16 
education. The strong association between costs and the Vineland composite standard score 
suggests that daily functioning is likely to be a strong and important indicator of a need for specialist 
or residential schooling. However, given the size of the R2 it is likely that there are also non-identified 
factors driving high costs.  
 
There are a number of limitations to the current study. First, the cost of informal care by family 
members, parental productivity losses, and out-of-pocket costs were not measured. These indirect 
costs have been proven to be high in children with autism (Jarbrink et al 2003) and it is therefore 
likely that there is a substantial additional cost for the families of adolescents with childhood autism, 
broader ASD and other SEN. Second, service use data were collected retrospectively by participant 
self-report (typically developing group only) or parental report (other groups) so costs may not be 
completely accurate. Although there is no evidence that alternative methods of data collection are 
more precise (Byford et al. 2006), the different approaches for the collection of data for the typically 
developing group means there may be some systematic bias. Third, the data reflect English service 
configurations so relevance to other settings will depend on similarities between health systems. 
Finally, these analyses are based on service use over six months during adolescence; lifetime costs of 
people with childhood autism, ASD and other SEN are likely to be higher and the relationship 
between their costs and those of their typically developing peers may change over time.   
 
A key strength of this paper is inclusion of comparison groups of other SEN and of typically 
developing controls. With this, we have been able to make firm conclusions regarding the additional 
cost of ASD rather than just the absolute cost of the condition, which was the focus of previous UK 
based studies (Barrett et al., 2011; Jarbrink et al., 2003; Knapp et al., 2009).  
 
The study has highlighted the importance of education as a key cost driver for those with childhood 
autism and other special needs and the very high financial implications of specialist and residential 
schooling. Further research could consider the relative cost-effectiveness of mainstream provision 
with support compared to specialist or residential provision in young people with ASD and other 
special educational needs and the possibility for early intervention that could facilitate the move to 
supported mainstream education. Clearly the value of services to young people and families cannot 
be estimated solely in financial terms, but the current study provides important data on financial 
costs. 
 
 9 
 
Table 1: Participant characteristics 
 Autism 
 
Broader 
ASD 
SEN 
 
Typical 
development 
Age in years, mean (SD) (n=149) 15.70 (0.54) 15.44 (0.38) 15.46 (0.38) 15.62 (0.68) 
Sex, % male (n=157) 94.44 86.95 88.46 100.00 
Ethnicity ,% non-white (n=157) 9.26 8.70 15.38 41.93 
IQ , mean (SD) (n=157) 84.16 
(18.48) 
84.48 
(17.69) 
69.46 
(15.58) 
103.61 
(12.89) 
Parental occupational status (n=108)     
 managerial, professional, % 17.39 26.19 10.00 * 
 intermediate, technical and routine, % 67.39 50.00 60.00 * 
 never worked and long-term unemployed, % 15.22 23.81 30.00 * 
ADI current social interaction score, mean (SD) 
(n=126) 
10.26 (3.90) 6.78 (3.07) 2.00 (1.81) * 
ADI current communication and language score, 
mean (SD) (n=126) 
9.11 (3.54) 7.21 (3.37) 3.08 (2.53) * 
ADI current restrictive and repetitive behaviour 
score, mean (SD) (n=126) 
5.52 (2.32) 3.89 (2.45) 0.69 (0.93) * 
ADOS social score, mean (SD) (n=126) 8.59 (3.12) 4.67 (2.88) 3.00 (2.04) * 
ADOS communication score, mean (SD) (n=126) 3.59 (2.00) 1.74 (1.27) 0.81 (0.90) * 
ADOS repetitive behaviour score, mean (SD) 
(n=126) 
2.78 (1.99) 1.33 (1.55) 0.62 (0.94) * 
ICD10 total score, mean (SD) (n=113) 9.73 (1.62) 6.29 (1.81) 1.52 (1.12) * 
Vineland composite standard score, mean (SD) 
(n=98) 
47.88 
(12.43) 
56.22 
(14.97) 
52.22 
(10.43) 
* 
SDQ total, mean (SD) (n=111) 26.39 (8.35) 26.02 (6.89) 21.84 (9.75) * 
*data not collected 
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Table 2: Service use (% with at least one contact) over six months follow-up 
 Autism 
(n=51) 
Broader ASD 
(n=45) 
SEN 
(n=24) 
Typical 
development 
(n=28) 
Respite and foster care     
Foster care, % 2 0 0 0 
Respite care, % 20 7 4 0 
Education      
Mainstream school, % 43 73 42 100 
Special school, % 47 24 50 0 
Residential school, % 10 2 4 0 
Home school, % 0 0 4 0 
SENCO, % 10 24 13 0.00 
Educational support services1 % 67 76 71 71 
Hospital services     
Inpatient stays, % 0.00 9 5 0.00 
Outpatient appointments, % 26 35 29 13 
A&E attendances, % 8 9 0 22 
Community services     
General practitioner, % 30 40 50 50 
Practice nurse, % 18 22 17 4 
Community paediatrician, % 6 2 0 4 
Social worker, % 18 9 13 0 
Psychologist, % 4 18 0 0 
Speech and language therapist, % 10 9 4 0 
Other community service2 % 16 18 0 18 
Medication     
Medication, % 40 51 33 25 
Voluntary services     
Voluntary services, %  20 31 0 0 
1 Education support services includes school counsellor, connexions and careers services, 
school/learning mentor, education welfare officer, education psychology  
2 Other community services includes physiotherapy and orthodontics 
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Table 3: Total cost, £, Mean (SD), range per adolescent over six months follow-up 
 Autism 
(n=51) 
Broader ASD 
(n=45) 
SEN 
(n=24) 
Typical development 
(n=28) 
Respite and foster 
care 
161 (519), 
0 to 2600 
76 (396),  
0 to 2600 
13 (61),  
0 to 300 
0 (0),  
0 to 0 
Education 10507 (6655),  
1045 to 30141 
8121 (6641),  
2512 to 40370 
8728 (6123),  
39 to 27772 
2639 (334),  
2512 to 4278 
Hospital services 74 (167),  
0 to 881 
359 (916),  
0 to 4722 
397 (1422),  
0 to 6968 
45 (80),  
0 to 265 
Community services 208 (528),  
0 to 2917 
184 (413),  
0 to 1989 
89 (293),  
0 to 1456 
267 (1292),  
0 to 6860 
Medication 32 (116),  
0 to 721 
168 (597),  
0 to 3496 
41 (130),  
0 to 540 
2 (10),  
0 to 52 
Voluntary services 47 (231),  
0 to 1568 
59 (213),  
0 to 1106 
0 (0) 
0 to 0 
0 (0) 
0 to 0 
Total  11029 (6747)  
1075 to 30944 
8968 (6889)  
2525 to 40959 
9268 (6489)  
342 to 27855 
2954 (1308)  
2512 to 9411 
Difference to typically 
developing group 
8075 6014 6315  
95% CI 5503 to 10647 3383 to 8645 3798 to 8832  
P-value <0.001 <0.001 <0.001  
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Table 4: Associations with cost for autism/broader ASD sample only 
Variable Number 
Mean cost 
(£) 
p-value 
Age*    
 <15.5 50 11275 0.035 
 >=15.5 46 8745  
Sex    
 Female 9 12115 0.348 
 Male 87 9850  
Ethnicity    
 White 87 10344 0.212 
 Non-white 9 7339  
Parent’s occupational class    
 managerial 19 10609 -- 
 intermediate 49 10022 0.761 
 never worked 16 11298 0.776 
Diagnosis    
 Broader PDD 45 8968 0.142 
 Autism 51 11029  
IQ*    
 <80 39 11441 0.023 
 >=80 57 9120  
ADI –current social interaction score*    
 <7 30 9534 0.642 
 >=7 66 10303  
ADI –current communication score*    
 <7 31 7750 0.007 
 >=7 65 11166  
ADI –current restrictive and repetitive behaviour score*    
 <4 30 8319 0.030 
 >=4 66 10855  
ADOS – social score*    
 <6 37 8399 0.167 
 >=6 59 11106  
ADOS – communication score*    
 <2 27 9245 0.044 
 >=2 69 10383  
ADOS – repetitive behaviour score*    
 <1 23 7432 0.003 
 >=1 73 10892  
ICD10 total symptoms*    
 <7 26 8107 0.112 
 >=7 70 10789  
Vineland composite standard score*    
 <52 36 12228 0.000 
 >=52 60 8763  
 13 
SDQ*    
 <24 35 10535 0.755 
 >24 61 9792  
* For continuous variables whilst analyses were carried out on continuous data, for ease of 
presentation, the difference in cost is shown in two groups split at the median.   
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Table 5 Multivariate model for Autism/broader ASD  sample  
Variable Coefficient 95% confidence interval p-value 
Age -4917 -7725 to -2109 0.001 
IQ 6 -81 to 93 0.889 
ADI –current communication score 259 -155 to 673 0.216 
ADI –current restrictive and repetitive behaviour 
score 
10 -521 to 540 0.971 
ADOS communication score 113 -628 to 853 0.763 
ADOS repetitive behaviour score 525 -202 to 1252 0.154 
Vineland composite standard score -156 -285 to -26 0.019 
Adjusted Rs=0.2464 
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